Congenital heart defects after maternal fever
Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-base...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics and gynecology 2014-04, Vol.210 (4), p.359.e1-359.e11 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 359.e11 |
---|---|
container_issue | 4 |
container_start_page | 359.e1 |
container_title | American journal of obstetrics and gynecology |
container_volume | 210 |
creator | Botto, Lorenzo D., MD Panichello, Janice D., PhD Browne, Marilyn L., PhD Krikov, Sergey, MS Feldkamp, Marcia L., PhD Lammer, Edward, MD Shaw, Gary M., DrPH |
description | Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, >3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention. |
doi_str_mv | 10.1016/j.ajog.2013.10.880 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1511820728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S000293781301990X</els_id><sourcerecordid>1511820728</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</originalsourceid><addsrcrecordid>eNo9kFtLxDAQhYMo7rr6B3yQPvrSOkl6SV4EWbzBgg8q-BZm2-na2osm7cL-e1N2FYYMmZwznHyMXXKIOPD0po6w7jeRAC79IFIKjticg87CVKXqmM0BQIRaZmrGzpyrp6vQ4pTNRMyVL5izcNl3G-qqAZvgk9AOQUEl5YMLsBzIBi36s_OPJW3JnrOTEhtHF4e-YO8P92_Lp3D18vi8vFuFuUzUEGY-SpEIpBRS1JlUOgbAOCedUCxjKeJ1hqBULjKtKcUCS5miUqVEVRRrKRfser_32_Y_I7nBtJXLqWmwo350hiecKwGZUF4q9tLc9s5ZKs23rVq0O8PBTJhMbSZMZsI0zXw2b7o67B_XLRX_lj8uXnC7F5D_5bYia_Km6qocmy_akav7cYLigxgnDJjXCe0EmkvgWsOH_AXMR3e9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1511820728</pqid></control><display><type>article</type><title>Congenital heart defects after maternal fever</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH</creator><creatorcontrib>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH ; National Birth Defects Prevention Study</creatorcontrib><description>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, >3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2013.10.880</identifier><identifier>PMID: 24184180</identifier><language>eng</language><publisher>United States</publisher><subject>Antipyretics - therapeutic use ; Case-Control Studies ; Female ; Fever - drug therapy ; Fever - epidemiology ; Heart Defects, Congenital - epidemiology ; Humans ; Infant, Newborn ; Obstetrics and Gynecology ; Pelvic Inflammatory Disease - epidemiology ; Pregnancy ; Pregnancy Complications - drug therapy ; Pregnancy Complications - epidemiology ; Respiratory Tract Infections - epidemiology ; Risk Assessment ; United States - epidemiology ; Urinary Tract Infections - epidemiology ; Vitamins - therapeutic use</subject><ispartof>American journal of obstetrics and gynecology, 2014-04, Vol.210 (4), p.359.e1-359.e11</ispartof><rights>Mosby, Inc.</rights><rights>Copyright © 2014 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</citedby><cites>FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24184180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Botto, Lorenzo D., MD</creatorcontrib><creatorcontrib>Panichello, Janice D., PhD</creatorcontrib><creatorcontrib>Browne, Marilyn L., PhD</creatorcontrib><creatorcontrib>Krikov, Sergey, MS</creatorcontrib><creatorcontrib>Feldkamp, Marcia L., PhD</creatorcontrib><creatorcontrib>Lammer, Edward, MD</creatorcontrib><creatorcontrib>Shaw, Gary M., DrPH</creatorcontrib><creatorcontrib>National Birth Defects Prevention Study</creatorcontrib><title>Congenital heart defects after maternal fever</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, >3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</description><subject>Antipyretics - therapeutic use</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Fever - drug therapy</subject><subject>Fever - epidemiology</subject><subject>Heart Defects, Congenital - epidemiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Obstetrics and Gynecology</subject><subject>Pelvic Inflammatory Disease - epidemiology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Pregnancy Complications - epidemiology</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Risk Assessment</subject><subject>United States - epidemiology</subject><subject>Urinary Tract Infections - epidemiology</subject><subject>Vitamins - therapeutic use</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kFtLxDAQhYMo7rr6B3yQPvrSOkl6SV4EWbzBgg8q-BZm2-na2osm7cL-e1N2FYYMmZwznHyMXXKIOPD0po6w7jeRAC79IFIKjticg87CVKXqmM0BQIRaZmrGzpyrp6vQ4pTNRMyVL5izcNl3G-qqAZvgk9AOQUEl5YMLsBzIBi36s_OPJW3JnrOTEhtHF4e-YO8P92_Lp3D18vi8vFuFuUzUEGY-SpEIpBRS1JlUOgbAOCedUCxjKeJ1hqBULjKtKcUCS5miUqVEVRRrKRfser_32_Y_I7nBtJXLqWmwo350hiecKwGZUF4q9tLc9s5ZKs23rVq0O8PBTJhMbSZMZsI0zXw2b7o67B_XLRX_lj8uXnC7F5D_5bYia_Km6qocmy_akav7cYLigxgnDJjXCe0EmkvgWsOH_AXMR3e9</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Botto, Lorenzo D., MD</creator><creator>Panichello, Janice D., PhD</creator><creator>Browne, Marilyn L., PhD</creator><creator>Krikov, Sergey, MS</creator><creator>Feldkamp, Marcia L., PhD</creator><creator>Lammer, Edward, MD</creator><creator>Shaw, Gary M., DrPH</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Congenital heart defects after maternal fever</title><author>Botto, Lorenzo D., MD ; Panichello, Janice D., PhD ; Browne, Marilyn L., PhD ; Krikov, Sergey, MS ; Feldkamp, Marcia L., PhD ; Lammer, Edward, MD ; Shaw, Gary M., DrPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-7880d52ae606a97389400a4ce95e434324b7a088c2799e6adaf36a88f3a8ddb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antipyretics - therapeutic use</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Fever - drug therapy</topic><topic>Fever - epidemiology</topic><topic>Heart Defects, Congenital - epidemiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Obstetrics and Gynecology</topic><topic>Pelvic Inflammatory Disease - epidemiology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Pregnancy Complications - epidemiology</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Risk Assessment</topic><topic>United States - epidemiology</topic><topic>Urinary Tract Infections - epidemiology</topic><topic>Vitamins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Botto, Lorenzo D., MD</creatorcontrib><creatorcontrib>Panichello, Janice D., PhD</creatorcontrib><creatorcontrib>Browne, Marilyn L., PhD</creatorcontrib><creatorcontrib>Krikov, Sergey, MS</creatorcontrib><creatorcontrib>Feldkamp, Marcia L., PhD</creatorcontrib><creatorcontrib>Lammer, Edward, MD</creatorcontrib><creatorcontrib>Shaw, Gary M., DrPH</creatorcontrib><creatorcontrib>National Birth Defects Prevention Study</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Botto, Lorenzo D., MD</au><au>Panichello, Janice D., PhD</au><au>Browne, Marilyn L., PhD</au><au>Krikov, Sergey, MS</au><au>Feldkamp, Marcia L., PhD</au><au>Lammer, Edward, MD</au><au>Shaw, Gary M., DrPH</au><aucorp>National Birth Defects Prevention Study</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital heart defects after maternal fever</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>210</volume><issue>4</issue><spage>359.e1</spage><epage>359.e11</epage><pages>359.e1-359.e11</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Objective The purpose of this study was to evaluate whether maternal febrile illnesses in early pregnancy are associated with increased risk for congenital heart defects in the offspring and whether such risk is mitigated by multivitamin supplement use. Study Design From a multistate population-based case-control study (National Birth Defects Prevention Study), we compared maternal reports of first-trimester febrile illness from 7020 subjects with heart defects and 6746 unaffected control subjects who were born from 1997 through 2005. Relative risks were computed with no fever or infection during the first trimester as reference group and were adjusted for potential confounders. Results First-trimester febrile illness was reported by 7.4% of control mothers (1 in 13). Febrile genitourinary infections were associated with selected heart defects, particularly right-sided obstructive defects (odds ratios, >3) and possibly others, whereas common respiratory illnesses were associated with low-to-negligible risks for most heart defects. When risk estimates were elevated, they tended to be mitigated when multivitamin supplements had been taken in the periconceptional period. Conclusion The source of fever and the use of supplements appear to influence the risk for heart defects. This information can be helpful in counseling and research, in particular with regard to primary prevention.</abstract><cop>United States</cop><pmid>24184180</pmid><doi>10.1016/j.ajog.2013.10.880</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9378 |
ispartof | American journal of obstetrics and gynecology, 2014-04, Vol.210 (4), p.359.e1-359.e11 |
issn | 0002-9378 1097-6868 |
language | eng |
recordid | cdi_proquest_miscellaneous_1511820728 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antipyretics - therapeutic use Case-Control Studies Female Fever - drug therapy Fever - epidemiology Heart Defects, Congenital - epidemiology Humans Infant, Newborn Obstetrics and Gynecology Pelvic Inflammatory Disease - epidemiology Pregnancy Pregnancy Complications - drug therapy Pregnancy Complications - epidemiology Respiratory Tract Infections - epidemiology Risk Assessment United States - epidemiology Urinary Tract Infections - epidemiology Vitamins - therapeutic use |
title | Congenital heart defects after maternal fever |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A21%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20heart%20defects%20after%20maternal%20fever&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Botto,%20Lorenzo%20D.,%20MD&rft.aucorp=National%20Birth%20Defects%20Prevention%20Study&rft.date=2014-04-01&rft.volume=210&rft.issue=4&rft.spage=359.e1&rft.epage=359.e11&rft.pages=359.e1-359.e11&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2013.10.880&rft_dat=%3Cproquest_cross%3E1511820728%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1511820728&rft_id=info:pmid/24184180&rft_els_id=1_s2_0_S000293781301990X&rfr_iscdi=true |